We are exploring a new treatment approach for patients with endometrial cancer based on their molecular features. The goal is to see if this can improve survival rates and reduce the chance of cancer returning.
Health conditions and diseases that the clinical trial is designed to study and treat.
Mismatch Repair Deficient High-Risk Endometrial Cancer (MMRd HREC) is a type of endometrial cancer that occurs when the body's ability to repair DNA is impaired. This condition is often diagnosed in patients with specific histological features and can be aggressive, requiring treatment after surgery.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
